These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23225665)

  • 1. Effects of olanzapine on 31P MRS metabolic markers in schizophrenia.
    Nenadic I; Dietzek M; Langbein K; Rzanny R; Gussew A; Reichenbach JR; Sauer H; Smesny S
    Hum Psychopharmacol; 2013 Jan; 28(1):91-3. PubMed ID: 23225665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
    Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
    Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.
    Smesny S; Rosburg T; Nenadic I; Fenk KP; Kunstmann S; Rzanny R; Volz HP; Sauer H
    Neuroimage; 2007 Apr; 35(2):729-37. PubMed ID: 17276699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia.
    Jayakumar PN; Gangadhar BN; Venkatasubramanian G; Desai S; Velayudhan L; Subbakrishna D; Keshavan MS
    Psychiatry Res; 2010 Mar; 181(3):237-40. PubMed ID: 20153149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study.
    Gangadhar BN; Jayakumar PN; Subbakrishna DK; Janakiramaiah N; Keshavan MS
    Am J Psychiatry; 2004 Jul; 161(7):1304-6. PubMed ID: 15229069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
    Smith RC; Lindenmayer JP; Hu Q; Kelly E; Viviano TF; Cornwell J; Vaidhyanathaswamy S; Marcovina S; Davis JM
    Schizophr Res; 2010 Jul; 120(1-3):204-9. PubMed ID: 20457512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study].
    Szulc A; Galińiska B; Tarasów E; Dzienis W; Kubas B; Konarzewska B; Waszkiewicz N; Popławska R
    Psychiatr Pol; 2010; 44(3):415-26. PubMed ID: 20672520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients.
    Qiao Y; Zhang L; He S; Wen H; Yu YM; Cao CH; Li HF
    Neurosci Lett; 2016 Mar; 617():270-6. PubMed ID: 26924724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo.
    Blüml S; Tan J; Harris K; Adatia N; Karme A; Sproull T; Ross B
    J Comput Assist Tomogr; 1999; 23(2):272-5. PubMed ID: 10096336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.
    Yacubian J; de Castro CC; Ometto M; Barbosa E; de Camargo CP; Tavares H; Cerri GG; Gattaz WF
    Schizophr Res; 2002 Dec; 58(2-3):117-22. PubMed ID: 12409151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest.
    Shirayama Y; Yano T; Takahashi K; Takahashi S; Ogino T
    Eur J Neurosci; 2004 Aug; 20(3):749-56. PubMed ID: 15255985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
    Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG
    Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies.
    Shioiri T; Hamakawa H; Kato T; Fujii K; Murashita J; Inubushi T; Someya T
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(4):169-74. PubMed ID: 11009069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Br J Psychiatry; 2004 May; 184():409-15. PubMed ID: 15123504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia.
    Panenka WJ; Khorram B; Barr AM; Smith GN; Lang DJ; Kopala LC; Vandorpe RA; Honer WG
    Schizophr Res; 2007 Aug; 94(1-3):288-92. PubMed ID: 17570643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study.
    Potvin S; Lungu OV; Stip E
    J Clin Psychopharmacol; 2015 Feb; 35(1):82-3. PubMed ID: 25370126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.